KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Stereotaxis (STXS) EBITDA (2016 - 2025)

Historic EBITDA for Stereotaxis (STXS) over the last 17 years, with Q3 2025 value amounting to -$6.6 million.

  • Stereotaxis' EBITDA fell 334.12% to -$6.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$24.1 million, marking a year-over-year decrease of 746.79%. This contributed to the annual value of -$24.7 million for FY2024, which is 1327.9% down from last year.
  • Stereotaxis' EBITDA amounted to -$6.6 million in Q3 2025, which was down 334.12% from -$4.0 million recorded in Q2 2025.
  • Over the past 5 years, Stereotaxis' EBITDA peaked at -$1.5 million during Q1 2021, and registered a low of -$7.6 million during Q4 2024.
  • Moreover, its 5-year median value for EBITDA was -$5.2 million (2022), whereas its average is -$5.0 million.
  • Per our database at Business Quant, Stereotaxis' EBITDA tumbled by 19557.8% in 2021 and then surged by 3394.78% in 2025.
  • Stereotaxis' EBITDA (Quarter) stood at -$3.3 million in 2021, then plummeted by 33.05% to -$4.5 million in 2022, then dropped by 19.03% to -$5.3 million in 2023, then plummeted by 43.8% to -$7.6 million in 2024, then increased by 14.03% to -$6.6 million in 2025.
  • Its EBITDA stands at -$6.6 million for Q3 2025, versus -$4.0 million for Q2 2025 and -$5.9 million for Q1 2025.